Epstein-Barr Virus and Human Disease · 1990

  • Editors
  • D. V. Ablashi
  • A. T. Huang
  • J. S. Pagano
  • G. R. Pearson
  • C. S. Yang
  • Kristinë L. Ablashi

Part of the Experimental Biology and Medicine book series (EBAM, volume 24)

Table of contents

  1. Front Matter
    Pages i-xliv
  2. Molecular Biology of EBV

    1. Front Matter
      Pages 1-1
    2. Nancy Raab-Traub, Hiroshi Sato, Kevin Gilligan, Pathmanathan Rajadurai, Toru Takimoto
      Pages 3-12
    3. W. G. Bradley, M. Tsuji, P. K. Lai, A. Tanaka, M. Nonoyama
      Pages 19-25
    4. G. Miller, N. Taylor, J. Kolman, R. Baumann, D. Katz, H. Himmelfarb et al.
      Pages 27-42
    5. F. Wang, H. Kikutani, S. Tsang, T. Kishimoto, E. Kieff
      Pages 43-46
    6. S. Tsang, F. Wang, E. Kieff
      Pages 47-51
    7. Nancy S. Sung, Shannon Kenney, David Gutsch, Joseph S. Pagano
      Pages 53-57
    8. Cliona M. Rooney, M. Brimmell, G. Allan, P. Farrell, M. Buschle
      Pages 65-67
    9. M. R. Chen, T. Y. Hsu, J. Y. Chen, C. S. Yang
      Pages 81-85
    10. S. Kenney, E. Holley-Guthrie, D. Gutsch, J-F. Giot, A. Sergeant
      Pages 93-97
    11. Manfred Marschall, Fritz Schwarzmann, Peter Alliger, Hans Wolf
      Pages 111-115
    12. W. Hinderer, H. Nebel-Schickel, J. Horn, R. Vornhagen, H.-H. Sonneborn, M. Gorgievski-Hrisoho et al.
      Pages 123-125
  3. Pathobiology of EBV

    1. Front Matter
      Pages 131-131
    2. T. Tursz, G. Rousselet, P. Busson, Q. Zhang, C. Biguet, B. Mariame et al.
      Pages 133-142
    3. J. Gosselin, L. Flamand, M. D’Addario, J. Hiscott, J. Menezes
      Pages 147-151
    4. K. Gilligan, H. Sato, Y. Lin, P. Rajadurai, P. Busson, T. Tursz et al.
      Pages 153-156
    5. L. Karran, Y. Gao, P. R. Smith, M. Lung, M. Ng, J. Sham et al.
      Pages 157-161
  4. Immunology of EBV

    1. Front Matter
      Pages 181-181
    2. Gary R. Pearson
      Pages 183-189
    3. D. J. Moss, T. B. Sculley, I. S. Misko, S. R. Burrows, R. Khanna, C. A. Jacob
      Pages 191-200
    4. Richard J. Pither, Chang X. Zhang, Lesley E. Wallace, Alan B. Rickinson, Andrew J. Morgan
      Pages 207-211
    5. L. E. Wallace, J. Wright, S. P. Lee, D. O. Ulaeto, A. J. Morgan, A. B. Rickinson
      Pages 213-217
    6. W. Jilg, H. Mairhofer, H. Wolf
      Pages 219-223
    7. A. Apolloni, R. Stumm, S. Burrows, D. J. Moss, I. S. Misko, T. B. Sculley
      Pages 225-229
    8. W. L. Goldschmidts, K. Bhatia, M. Carolan, J. Luka, I. T. Magrath
      Pages 237-240
  5. EBV Associated Lymphoproliferative Disorders

    1. Front Matter
      Pages 241-241
    2. I. T. Magrath, M. Rowe, A. H. Filipovich, R. Shapiro, I. J. Su, T. Sculley
      Pages 243-272
    3. R. F. Ambinder, T-C Wu, B. Lambe, J. Zhang, P. Charache, B. A. Zehnbauer et al.
      Pages 277-281
    4. K. Kawa-Ha, S. Ishihara, J. Hara, K. Nasu, N. Imamura, K. Oshimi
      Pages 283-287
    5. H. Cen, M. C. Breinig, M. Ho, J. L. C. McKnight
      Pages 289-293
    6. D. T. Purtilo, K. Falk, R. McCarthy, S. J. Pirruccello, H. Nakamine, K. Kleveland et al.
      Pages 295-300
    7. Cliona M. Rooney, Barbara S. Baker
      Pages 301-304
    8. Masanori Daibata, Shuji Takagi, Robert E. Humphreys, Kenzo Takada, Takeshi Sairenji
      Pages 305-309

About this book


The Epstein-Barr virus (EBV), isolated in 1966, continues to draw worldwide attention as an important human pathogen. Its impor­ tance is largely related to the continuing accumulation of evidence that implicates EBV as an etiological factor for certain types of human cancer. More recent investigations on this virus have focused on the identity of the viral genes responsible for the different disease mani­ festations observed following viral infection. It is hoped that by thorough investigation of this virus, clues to how cancer develops from a normal cell will surface. In addition, many of the gene products are now being exploited for the development of new and more sensitive tests for the diagnosis and clinical management of individu­ als with EBV -associated diseases. Thus, studies on this virus continue to provide new information of importance to our understanding of the malignant process. In an effort to attract both basic and clinical scientists to the same meeting for purposes of scientific exchange and fostering a closer interaction between these individuals, a series of international symposia was initiated in 1984. The first meeting was held in Loutraki, Greece, and was attended by approximately 100 participants. The second international symposium was held in St. Petersburg, Florida, in 1986, and was attended by approximately twice as many partici­ pants as attended the Loutraki meeting.


DNA Promoter Translation cell lines genes molecular biology transcription

Bibliographic information

Industry Sectors
Consumer Packaged Goods